Neuromyelitis Optica Spectrum Disorder: An Early Diagnosis to Prevent Blindness and Paraplegia

被引:0
|
作者
George, Minny [1 ]
Gantioque, Raymund [1 ]
机构
[1] Calif State Univ, Sch Nursing, 5151 State Univ Dr, Los Angeles, CA 90032 USA
来源
关键词
Devic's disease; monoclonal antibodies; neuromyelitis optica; neuromyelitis optica (NMO) antibody AQP4-IgG; neuromyelitis optica spectrum disorder; optic neuritis; transverse myelitis; MULTICENTER; EFFICACY; SAFETY; TRIAL;
D O I
10.1016/j.nurpra.2023.104654
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Neuromyelitis optica spectrum disorder (NMOSD), also referred to as Devic's disease, is a rare autoimmune disease of the central nervous system that primarily affects both the optic nerve (optic neuritis) and the spinal cord (myelitis). Patients presenting solely with optic neuritis or transverse myelitis can make diagnosis difficult. If left untreated, it may result in blindness and paralysis. Early and accurate diagnosis is crucial for treating and preventing further NMOSD attacks. This article describes the case of a previously healthy patient who presented with NMOSD. In addition, the clinical presentation, diagnostics, and treatment methods are discussed.& COPY; 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Urinalysis in patients with neuromyelitis optica spectrum disorder
    Chen, Z. G.
    Huang, J.
    Fan, R.
    Weng, R. H.
    Shinohara, R. T.
    Landis, J. R.
    Chen, Y.
    Jiang, Y.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (04) : 619 - 625
  • [32] Frequency of comorbidities in Neuromyelitis Optica spectrum disorder
    Barzegar, Mahdi
    Mirmosayyeb, Omid
    Nehzat, Nasim
    Vaheb, Saeed
    Shaygannejad, Vahid
    Asgari, Nasrin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 48
  • [33] A new era for neuromyelitis optica spectrum disorder
    Silbermann, Elizabeth
    Bourdette, Dennis
    LANCET, 2019, 394 (10206): : 1304 - 1305
  • [34] Neuromyelitis Optica Spectrum Disorder Presented with Pseudoathetosis
    Seok, Hung Youl
    Eun, Mi-Yeon
    Jang, Seong Hwa
    You, Sooyeoun
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 419 - 419
  • [35] Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder
    Simon Fung
    Matt Shirley
    CNS Drugs, 2023, 37 : 363 - 370
  • [36] Hemifacial anhidrosis in neuromyelitis optica spectrum disorder
    Miyaue, Noriyuki
    Yabe, Hayato
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (02): : 107 - 108
  • [37] Choroid Plexitis in Neuromyelitis Optica Spectrum Disorder
    Oh, Y. J.
    Lim, Y. M.
    Lee, E. J.
    Kim, H. J.
    Kim, K. K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 380 - 381
  • [38] Neuromyelitis Optica Spectrum Disorder: A Case Report
    Yaregal, Samson
    Bekele, Nebiyu
    Gebrewold, Yonathan
    Tadesse, Abilo
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 643 - 648
  • [39] Membranous nephropathy with Neuromyelitis optica spectrum disorder
    Li, Xiangling
    Wang, YanQiang
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 15 : 49 - 51
  • [40] Controversies in the management of neuromyelitis optica spectrum disorder
    Bruscolini, Alice
    La Cava, Maurizio
    Mallone, Fabiana
    Marcelli, Michela
    Ralli, Massimo
    Sagnelli, Paolo
    Greco, Antonio
    Lambiase, Alessandro
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (11) : 1127 - 1133